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Objective: In this exploratory open label study, we investigated the prevalence of cata-
tonia in an acute psychiatric inpatient population. In addition, differences in symptom
presentation of catatonia depending on the underlying psychiatric illness were investigated.
Methods: One hundred thirty patients were assessed with the Bush–Francis Catatonia
Rating Scale (BFCRS), the Positive and Negative Syndrome Scale, theYoung Mania Rating
Scale, and the Simpson–Angus Scale. A factor analysis was conducted in order to gener-
ate six catatonic symptom clusters. Composite scores based on this principal component
analysis were calculated.
Results: When focusing on the first 14 items of the BFCRS, 101 patients (77.7%) had
at least 1 symptom scoring 1 or higher, whereas, 66 patients (50.8%) had at least 2
symptoms. Interestingly, when focusing on the DSM-5 criteria of catatonia, 22 patients
(16.9%) could be considered for this diagnosis. Furthermore, different symptom profiles
were found, depending on the underlying psychopathology. Psychotic symptomatology
correlated strongly with excitement symptomatology (r=0.528, p<0.001) and to a lesser
degree with the stereotypy/mannerisms symptom cluster (r= 0.289; p=0.001) and the
echo/perseveration symptom cluster (r=0.185; p=0.035). Similarly, manic symptomatol-
ogy correlated strongly with the excitement symptom cluster (r=0.596; p<0.001) and to
a lesser extent with the stereotypy/mannerisms symptom cluster (r=0.277; p=0.001).
Conclusion:There was a high prevalence of catatonic symptomatology. Depending on the
criteria being used, we noticed an important difference in exact prevalence, which makes it
clear that we need clear-cut criteria. Another important finding is the fact that the catatonic
presentation may vary depending on the underlying pathology, although an unambiguous
delineation between these catatonic presentations cannot be made. Future research is
needed to determine diagnostical criteria of catatonia, which are clinically relevant.
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INTRODUCTION
Catatonia is a psychomotor symptom cluster characterized by a
heterogeneous group of mental, motor, vegetative, and behavioral
signs. The recognition of catatonia is essential since it is a syndrome
that can be effectively and rapidly relieved in most cases. Whereas,
the pathophysiology of catatonia is still unknown, it is clear that
the psychomotor syndrome results from many etiologies (1).
Although some critics have suggested the syndrome is much
more uncommon than a century ago or may even be disappearing,
catatonia is still highly prevalent (2). Whereas early investigators
reported catatonia in 20–50% of the schizophrenic patients (3, 4),
contemporary literature demonstrates the presence of catatonia in
4–15% of schizophrenia patients (5–8). In acutely ill psychiatric
inpatients higher estimates are reported, ranging between 5 and
20% (9, 10).
Most recently, the DSM-5 rightfully loosened the association
between schizophrenia and catatonia that was predominant in
its preceding editions and now recognizes that catatonia can be
induced by different disorders (11). In the study of Pommepuy
and Januel, including 607 catatonic patients, there was an average
of 30.9% of all patients with a primary diagnosis of schizophre-
nia, whereas 43% of the patients had a mood disorder (12). The
review of Caroff and colleagues shows similar results (13). Among
patients with a mood disorder, catatonia can be seen in patients
with a bipolar disorder with a percentage of 17–47% in mania and
0–20% in patients with a depressive episode (14, 15). In a study
including patients with an unipolar depressive disorder 20% of
the patients met the criteria for catatonia (16).
There are reasons to believe that the profile of catatonic symp-
tomatology may depend on the underlying pathology (15, 17).
Krüger and colleagues demonstrated that catatonia in schiz-
ophrenia was mainly characterized by abnormal movements,
stereotypies, mannerisms, catalepsy, negativism, automatic obe-
dience, and waxy flexibility, whereas, catatonic excitation was
more associated with mania and catatonic inhibition more with
depression (15). This notion is very intriguing since it can both
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have diagnostical and therapeutical implications and give clues
toward future research on the underlying pathophysiology of the
psychomotor syndrome.
In the present study, prevalence of catatonia in an acute psy-
chiatric inpatient population was investigated. In addition, dif-
ferences in symptom presentation of catatonia depending on the
underlying psychiatric illness were investigated.
MATERIALS AND METHODS
STUDY DESIGN
In an exploratory open label study design, each patient admitted
to a psychiatric intensive ward during a period of 12 months was
assessed for catatonic and clinical symptomatology. The patients
admitted to this department were experiencing the most acute
phase of a mental illness. The department is for men and women
over the age of 18 year who require a period of psychiatric intensive
care. The assessments were conducted on the first day of admission
in the hospital. There were no exclusion criteria for participa-
tion. All of the 130 patients who were admitted to the psychiatric
intensive ward were included in the study.
PARTICIPANTS
A total group of 130 patients (female: n= 50; 38.5%) were tested
after admission on an acute psychiatric enclosed ward. The mean
age was 40.5 years (SD= 13.9; range 18–76). More than half of
our patient group had a psychotic illness as a primary illness
(n= 67; 51.5%) including 26 patients (20.0%) with schizophrenia
(amongst which 3 patients with a diagnosed catatonic subtype)
and 35 patients with a psychotic illness not otherwise specified
(26.9%). The second most common primary diagnosis (n= 16;
12.3%) was a bipolar disorder, followed by substance abuse dis-
orders (n= 14; 10.8%). Major depressive disorder was the main
diagnosis in six patients (4.6%). Similarly, six patients received a
diagnosis of personality disorder (4.6%).
Antipsychotics were taken by 56.9% of the patients (n= 74).
Twenty-six patients (20.0%) took at least 1 first generation antipsy-
chotic (FGA), whereas 64 patients (49.2%) took a second genera-
tion antipsychotic (SGA), 4 patients were taking lithium (3.1%),
whereas 12 patients took anti-epileptics (9.2%) at the time of test-
ing. Antidepressants were administered to 30.8% of the patients
at the time of testing [SSRI (n= 17); SNRI (n= 10); TCA (n= 2);
and others (n= 5)]. Finally, 40% of the patients were taking
benzodiazepines (n= 52) and 6 patients took an anticholinergic
agent (4.6%).
CLINICAL ASSESSMENT
All patients were assessed with the Bush–Francis Catatonia Rat-
ing Scale (BFCRS) (18), the Positive and Negative Syndrome Scale
(PANSS) (19), the Young Mania Rating Scale (YMRS), and the
Simpson–Angus Scale (SAS).
The BFCRS is used to recognize and score catatonic signs and
symptoms. It measures the severity of 23 catatonic signs. By scor-
ing the first 14 items of the BFCRS, the instrument can be used as a
screening tool. If two or more of the BFCRS signs are present, the
presence of catatonia can be considered. Items of the BFCRS are
scored on a 0–3 point scale. The PANSS is a widely used medical
scale for measuring symptom severity of patients with schizophre-
nia. Scores ranging from 1 to 7 are given on 30 different symptoms
in three subscales (positive scale 7 items, negative scale 7 items,
general psychopathology scale 16 items), with total score ranging
from 30 to 210. In order to measure depressive symptoms we used
a depression-subscale of the PANSS (PANSS-dep) including items
depression, anxiety and guilt feelings. The YMRS is a rating scale
to assess manic symptoms. The scale has 11 items and is based on
the patient’s subjective report of his or her clinical condition over
the previous 48 h. Additional information is based upon clinical
observations made during the course of the clinical interview. The
SAS is used to measure extrapyramidal symptoms. It is composed
of 10 items and signs.
RESULTS
CATATONIA SYMPTOMATOLOGY
Catatonic symptomatology was highly prevalent in our patient
sample. When focusing on the first 14 items of the BFCRS, which
are suggested for using the instrument as a screening tool, 101
patients (77.7%) had at least 1 symptom scoring 1 or higher,
whereas 66 patients (50.8%) had at least 2 symptoms. Interest-
ingly, when focusing on the DSM-5 criteria of catatonia (at least
3 out of 12 selected symptoms), 22 patients (16.9%) fulfill the
diagnostic criteria, which still implied a high prevalence rate, but
drastically lower than when using the BFCRS-criteria, and inter-
estingly and unexpectedly, also lower than with the DSM-IV-TR
criteria (see Table 1).
In our patient sample, the most prevalent catatonic symptoms
were excitement (n= 49; 37.7%), perseveration (n= 32; 24.6%),
impulsivity (n= 31; 23.8%), and verbigeration (n= 31; 23.8%),
whereas, a grasp reflex or waxy flexibility could not be observed
in any of the patients. Similarly, catatonic symptoms such as mit-
gehen (n= 3; 2.3%), gegenhalten (n= 2; 1.5%), or ambitendency
(n= 3; 2.3%) could only seldomly be observed (see Table 2).
A factor analysis (Principal Component Analysis, varimax
rotation) was conducted in order to generate catatonic symp-
tom clusters. Given that items grasp reflex and waxy flexibil-
ity had a zero variance, these items were excluded from the
analysis. This yielded six symptom clusters (see Table 3): a
negative factor including immobility/stupor, mutism, staring, pos-
turing, rigidity, negativism, withdrawal, gegenhalten, and ambi-
tendency; a stereotypy/mannerism factor including stereotypy,
Table 1 | Prevalence of catatonia in an acute psychiatric patient
sample according to different criteria.
DSM-IV
(20)
DSM-V
(11)
BFCRS
(18)
Fink and
Taylor (21, 22)
Psychotic
disorder
19 (28.4%) 14 (20.9%) 48 (71.6%) 9 (13.4%)
Mood disorder 7 (31.8%) 5 (22.7%) 17 (77.3%) 5 (22.7%)
Substance use
disorder
1 (7.1%) 0 (0%) 3 (21.4%) 0 (0%)
Another diagnosis 5 (18.5%) 3 (11.1%) 14 (51.9%) 2 (7.4%)
Total patient
group
32 (24.6%) 22 (16.9%) 82 (63.1%) 16 (12.3%)
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Table 2 | Scores on the individual items of the BFCRS.
Score=0
(absent symptom)
Score=1 Score=2 Score=3 Patients with
symptom (N )
Excitement 81 35 14 0 49
Immobility/stupor 107 18 5 0 23
Mutism 117 4 6 3 13
Staring 101 22 5 2 29
Posturing/catalepsy 112 11 4 3 18
Grimacing 119 11 0 0 11
Echopraxia/echolalia 126 3 1 0 4
Stereotypy 104 19 6 1 26
Mannerisms 114 7 7 2 16
Verbigeration 99 17 12 2 31
Rigidity 115 13 2 0 15
Negativism 124 5 1 0 6
Waxy flexibility 130 0 0 0 0
Withdrawal 107 12 6 5 23
Impulsivity 99 13 18 0 31
Automatic obedience 121 4 5 0 9
Mitgehen 127 0 0 3 3
Gegenhalten 128 0 0 2 2
Ambitendency 127 0 0 3 3
Grasp reflex 130 0 0 0 0
Perseveration 98 0 0 32 32
Combativeness 112 15 2 1 18
Autonomic abnormality 116 13 1 0 14
mannerisms, and mitgehen; an echo/perseveration factor includ-
ing echophenomena, verbigeration, and perseveration; an excite-
ment factor encompassing items excitement, impulsivity, and
combativeness; a grimacing factor only including that specific
item, and finally, an autonomic factor including autonomic abnor-
malities and, strangely, automatic obedience. Composite scores
based on this principal component analysis were calculated.
CLINICAL SYMPTOMATOLOGY
All patients completed the PANSS. Out of the total patient group,
88 (67.7%) had a PANSS-pos score higher than 14 reflecting a
symptom state that was higher than dubious and 51 patients
(39.2%) had at least mild psychotic symptomatology (i.e., a
PANSS-pos score of 21 or higher). Similarly, all patients com-
pleted a YMRS: 29 patients (22.3%) had a score of 20 or higher,
reflecting (hypo)manic symptomatology whereas only 34 patients
(26.2%) had an absent of manic symptomatology (i.e., a maximum
score of 6).
TO WHAT EXTENT IS THE CATATONIC SYMPTOMATOLOGY
DETERMINED BY THE UNDERLYING DIAGNOSIS?
The total patient sample was divided in four groups: patients
with a psychotic disorder (n= 67; 51.5%), patients with a mood
disorder (n= 22; 16.9%; composed of 16 bipolar patients and
6 patients with a major depressive disorder), patients with a
substance use disorder (SUD; n= 14; 10.8%), and patients with
another diagnosis (patients-OD; n= 27; 20.8%).
Patients with a psychotic or mood disorder as a primary diag-
nosis had the most prominent catatonic symptom profiles (see
Figure 1).
Compared to patients with a SUD or the patient-OD
group psychotic patients tended to score higher on the stereo-
typy/mannerism symptom cluster (SUD: p= 0.044; patient-
OD: p= 0.076), the negative symptom cluster (SUD: p= 0.069;
patient-OD: p= 0.121), and on the excitement symptom cluster
(SUD: p= 0.021; patient-OD: p= 0.063). No differences between
the psychosis group and the combined mood disorder group could
be seen. However, when only the bipolar patients entered analy-
ses, these patients had significant more excitement symptoms
(p= 0.015) than the patients with a psychotic illness, whereas, the
latter group had significantly more excitement symptoms com-
pared to the major depressive disorder group (p= 0.029). Very
similar results were found after controlling for extrapyramidal
symptomatology by use of the total score on the SAS. These
results could mostly be explained by the fact that the SUD- and
patient-OD groups hardly showed any catatonic symptomatology.
Psychotic symptomatology correlated strongly with excite-
ment symptomatology (r = 0.528, p< 0.001) and to a lesser
degree with the stereotypy/mannerisms symptom cluster
(r = 0.289; p= 0.001) and the echo/perseveration symptom clus-
ter (r = 0.185; p= 0.035). Similarly, manic symptomatology as
assessed by the YMRS correlated strongly with the excitement
symptom cluster (r = 0.596; p< 0.001) and to a lesser extent
with the stereotypy/mannerisms symptom cluster (r = 0.277,
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Table 3 | Factor analysis (principal component analysis), varimax rotation on the items of the BFCRSa.
Negative
factor
Stereotypy/mannerisms
factor
Echo/perseveration
factor
Excitement
factor
Grimacing
factor
Autonomic
factor
Excitement −0,320 0,509 0,070 0,442 0,070 −0,156
Immobility/stupor 0,836 −0,06 0,096 −0,135 −0,019 −0,143
Mutism 0,837 0,013 −0,068 −0,069 0,047 −0,177
Staring 0,790 0,140 0,086 −0,111 0,055 0,105
Posturing/catalepsy 0,900 0,007 −0,038 −0,037 0,006 −0,094
Grimacing −0,065 0,142 −0,046 0,180 0,637 −0,065
Echopraxia/echolalia −0,092 −0,209 0,756 −0,066 0,204 −0,247
Stereotypy −0,074 0,830 0,096 0,008 −0,026 −0,005
Mannerisms 0,139 0,608 −0,071 0,215 0,053 0,138
Verbigeration 0,109 0,188 0,727 0,070 −0,149 0,270
Rigidity 0,777 0,069 0,146 0,096 −0,034 0,183
Negativism 0,663 0,115 0,033 0,137 0,490 0,257
Withdrawal 0,665 −0,129 −0,199 0,004 −0,219 −0,103
Impulsivity 0,112 0,492 0,134 0,399 0,192 0,030
Automatic obedience −0,047 0,068 0,010 0,154 −0,068 0,714
Mitgehen 0,075 0,688 −0,018 −0,403 0,270 −0,127
Gegenhalten 0,678 −0,016 0,164 0,280 −0,041 0,053
Ambitendency 0,650 0,223 0,004 −0,069 0,545 0,068
Perseveration 0,243 0,348 0,560 −0,036 −0,403 0,09
Combativeness 0,006 0,068 −0,050 0,728 0,147 −0,018
Autonomic Abnormality −0,033 −0,109 0,042 −0,285 0,053 0,660
aItems waxy flexibility and grasp reflex were excluded from this analysis, because of the zero variance on these items.
Composite scores based on this principal component analysis (symptoms scores in bold) were calculated.
FIGURE 1 | Distribution of catatonic signs.
p= 0.001). It should be noted that the PANSS-pos subscale and
the YMRS strongly intercorrelated (r = 0.695; p< 0.011), which
undoubtedly confounded these results.
A PANSS-dep was calculated including items depression, anx-
iety, and guilt feelings. Kontaxakis and colleagues found this sub-
scale to intercorrelate with the Hamilton Depression subscale (23).
Frontiers in Psychiatry | Schizophrenia December 2014 | Volume 5 | Article 174 | 4
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stuivenga and Morrens Relevance of catatonia
PANSS-dep was inversely correlated with the grimacing factor
(r =−0.288; p= 0.001) and tended toward an inversely correla-
tion with the excitement factor (r =−0.170;p= 0.054), suggesting
that depressive patients had these catatonic symptoms to a lesser
degree than their non-depressed peers.
The total score on the SAS also correlated with the nega-
tive catatonia symptomatology (r = 0.350; p< 0.001) and with
the echo/perseveration symptoms (r = 0.318; p< 0.001), which
suggests that catatonic symptoms and extrapyramidal symptoms
could not clearly be delineated from each other in our patient
sample.
DISCUSSION
Out of the 130 patients that were admitted to an enclosed psychi-
atric ward, 101 patients (77.7%) had at least 1 symptom, whereas
66 patients (50.8%) had at least 2 symptoms when screened for
catatonia symptoms, irrespective of the underlying diagnosis. In
other words, catatonic symptomatology was highly prevalent in
our patient population, although in most cases mildly. The most
prevalent catatonic symptoms were excitement (n= 49; 37.7%),
perseveration (n= 32; 24.6%), impulsivity (n= 31; 23.8%), and
verbigeration (n= 31; 23.8%).
Our current findings demonstrate the presence of at least one
symptom that is labeled as being catatonic by the BFCRS in most
of the patients admitted to an enclosed psychiatric ward. In other
studies, catatonia has been reported in 5–20% of acutely ill patients
admitted to psychiatric units (9, 10, 18, 21, 24–26). In these studies,
different criteria to diagnose catatonia were used, which renders a
comparison between different studies on the prevalence of catato-
nia more difficult. For example, in the study of Lee, DSM-criteria
were used to classify catatonia (24). When we used the latest DSM-
criteria, only 16.9% of the patients (n= 22) could be considered as
being catatonic. In the study of Ungvari, the diagnosis was made in
the presence of four or more signs or symptoms with at least one
having a score “2” or above on the BFCRS (26), which again, are
more strict criteria than those used in our study. Fink and Taylor
made their own diagnostic criteria with emphasis on the duration
of the catatonic symptoms (22). Consequently, these divergent
findings raise two interesting points. Depending on which crite-
ria are being used, the more strict DSM-criteria versus the more
liberal criteria suggested by Bush and colleagues (i.e., two items
on the BFCRS), very different prevalence rates were found, which
clearly emphasizes the shortcomings caused by a lack of clear-
cut criteria (27). Of note, the DSM-5 criteria for catatonia appear
to be even more strict than those of its predecessor, even if all
12 items, which were clustered in five categories in the DSM-IV
can now be scored separately. This is mainly due to the fact that
now three instead of two items have to be present. On the other
hand, the high prevalence of symptoms using the BFCRS-criteria
was mostly explained by the presence of mild symptomatology,
whereas, more severe symptoms were present in a minority of our
sample. Consequently, our results seem to point out that catatonic
features, and more broadly psychomotor symptoms, may deserve
a dimensional approach, much like cognitive symptoms associated
with these psychiatric illnesses (27). It should also be noted that
the most prevalent catatonic symptoms were not the strictly motor
symptoms, which mostly seem associated with the traditional view
on catatonia. Cognitive symptoms like perseveration and affec-
tive symptoms like excitement were the most prevalent and their
validity and specificity as catatonic features should be questioned,
especially in the more mild presentations. The unknown patho-
physiology may contribute to the different views on catatonia. An
unifying pathogenesis of catatonia that explains all motor, vege-
tative, and behavioral symptoms remains elusive. As a result, an
unclear clinical concept of catatonia exists with the use of different
diagnostical criteria and different rating scales to score catatonic
symptomatology.
In our study, no significant differences in overall prevalence of
catatonia between the psychosis group and the combined mood
disorder group could be seen. Other studies also show that the
syndrome is highly prevalent in both psychotic and mood disor-
ders (17). Several studies found that the frequency of catatonia
as part of schizophrenia varies with a range between 4 and 15%
(5–8). Slightly higher prevalence rates have been shown in mood
disorders with prevalence rates of 10–25% in bipolar disorder and
up to 20% of patients with an unipolar depressive disorder (14–16,
22). However, again, different criteria for catatonia were used in
these studies.
Different catatonia symptom profiles were found, depending
on the underlying psychopathology. Psychotic patients tended
to score higher on the stereotypy/mannerism symptom clus-
ter, the negative symptom cluster, and the excitement symptom
cluster compared to patients with a substance use disorder and
patients with another diagnosis, but not compared to patients
with mood disorders. In this line, psychotic symptomatology cor-
related strongly with excitement symptomatology and to a lesser
degree with the stereotypy/mannerisms symptom cluster and the
echo/perseveration symptom cluster. Similarly, manic symptoma-
tology correlated strongly with the excitement symptom cluster
and to a lesser extent with the stereotypy/mannerisms symptom
cluster. Kraepelin already suggested that catatonia had a different
symptomatology depending on the underlying pathology. Partly in
line with our results, he described that negativism and mannerism
were mainly associated to dementia praecox (4). Similarly, Schnei-
der compared patients with catatonic (schizophrenic) and manic
excitement, respectively and found that schizophrenic agitated
patients displayed more blocking, waxy flexibility, stereotyped
speech, mutism, and negativism (28). In a study of catatonic ado-
lescents, automatic obedience and stereotypies were significantly
more associated with schizophrenic than they were with non-
schizophrenic catatonia (29). Finally, Krüger and colleagues found
that catatonic chronic schizophrenia is mainly associated with
catalepsy, waxy flexibility, and volitional disturbances such as auto-
matic obedience and negativism, as well as mannerisms and abnor-
mal involuntary movements such as grimacing, jerky movements,
and stereotypies. In contrast, manic patients mainly displayed
catatonic excitement, whereas, depressed patients were charac-
terized by catatonic inhibition in terms of stupor, mutism, and
rigidity (15). This was also in line with our findings, since symp-
toms of excitement and combativeness was significantly more
present in the manic patients sample and significantly less in the
depressed group, when compared to the psychotic patients sample.
Some limitations of our study should be pointed out. First, the
impact of medication could be a confounding factor in our study.
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A vast number of patients were taking benzodiazepines at the time
of testing, which could have masked more severe presentations
of the catatonic syndrome. Another limitation of the study is the
lack of a depression scale. To overcome this limitation, we used
the PANSS-dep but a dedicated depression scale would have been
more elegant. Moreover, the sample size was rather small, espe-
cially in some subgroups. Larger scale trials are needed to replicate
our findings.
In conclusion, there was a high prevalence of catatonic symp-
tomatology. Remarkably, there is an important difference in exact
prevalence depending on the criteria being used, which makes it
clear that we need clear-cut criteria. Another important finding
is the fact that the catatonic presentation may vary depending on
the underlying pathology, although an unambiguous delineation
between these catatonic presentations cannot be made. Future
research is needed to determine diagnostical criteria of catatonia,
which are clinically relevant.
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